ConductScience.org, home

Trial · NCT01474109

Results by group27

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence Rate of New Digital Ulcers (DUs) up to Week 16Macitentan 3mg0.9082number of new DUs/observation days
Incidence Rate of New Digital Ulcers (DUs) up to Week 16Macitentan 10mg0.9567number of new DUs/observation days
Incidence Rate of New Digital Ulcers (DUs) up to Week 16Placebo0.8115number of new DUs/observation days
Percentage of Participants Without a New DU Up To Week 16Macitentan 3mg64.1Percentage of participants
Percentage of Participants Without a New DU Up To Week 16Macitentan 10mg63.0Percentage of participants
Percentage of Participants Without a New DU Up To Week 16Placebo67.0Percentage of participants
Percentage of Participants With at Least One DU ComplicationMacitentan 3mg14.1percentage of participants
Percentage of Participants With at Least One DU ComplicationMacitentan 10mg19.6percentage of participants
Percentage of Participants With at Least One DU ComplicationPlacebo19.1percentage of participants
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16Macitentan 3mgBaseline1.3Standard Deviation 0.73units on a scale
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16Macitentan 10mgBaseline1.4Standard Deviation 0.70units on a scale
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16PlaceboBaseline1.3Standard Deviation 0.68units on a scale
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16Macitentan 3mgWeek 161.2Standard Deviation 0.79units on a scale
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16Macitentan 10mgWeek 161.2Standard Deviation 0.66units on a scale
Change in Hand Functionality Health Assessment Questionnaire - Disability Index (HAQ-DI) Hand Component From Baseline to Week 16PlaceboWeek 161.2Standard Deviation 0.73units on a scale
Health Assessment Questionnaire - Disability Index (HAQ-DI) Overall Score From Baseline to Week 16Macitentan 3mgBaseline1.1Standard Deviation 0.71units on a scale
Health Assessment Questionnaire - Disability Index (HAQ-DI) Overall Score From Baseline to Week 16Macitentan 10mgBaseline1.2Standard Deviation 0.66units on a scale
Health Assessment Questionnaire - Disability Index (HAQ-DI) Overall Score From Baseline to Week 16PlaceboBaseline1.1Standard Deviation 0.62units on a scale
Health Assessment Questionnaire - Disability Index (HAQ-DI) Overall Score From Baseline to Week 16Macitentan 3mgWeek 161.1Standard Deviation 0.73units on a scale
Health Assessment Questionnaire - Disability Index (HAQ-DI) Overall Score From Baseline to Week 16Macitentan 10mgWeek 161.1Standard Deviation 0.64units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01474109/results